Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Drug discovery today ; h5-index 68.0

The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target identification, clinical design, regulatory decision-making, and pharmacovigilance. We specifically emphasize the potential role of AI-powered LMs for developing new treatments for Coronavirus 2019 (COVID-19) strategies, including drug repurposing, which can be extrapolated to other infectious diseases that have the potential to cause pandemics. Finally, we set out the remaining challenges and propose possible solutions for improvement.

Liu Zhichao, Roberts Ruth A, Lal-Nag Madhu, Chen Xi, Huang Ruili, Tong Weida


Artificial intelligence, COVID-19, Drug development, Drug discovery, Language models, Natural language processing